Literature DB >> 15962508

Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions.

Françoise Roux1, Pierre-Olivier Couraud.   

Abstract

(1) In vitro models of the BBB have been developed from cocultures between bovine, porcine, rodent or human brain capillary endothelial cells with rodent or human astrocytes. Since most in vivo BBB studies have been performed with small laboratory animals, especially rats, it is important to establish a rat brain endothelial (RBE) cell culture system that will allow correlations between in vitro and in vivo results. The present review will constitute a brief description of the best characterized RBE cell lines (RBE4, GP8/3.9, GPNT, RBEC1, TR-BBBs and rBCEC4 cell lines) and will summarize their recent and important contribution to our current knowledge of the BBB transport functions and permeability to blood-borne solutes, drugs, and cells. (2) In most cases, primary cultures of RBE cells were transduced with an immortalizing gene (SV40 or polyoma virus large T-antigen or adenovirus E1A), either by transfection of plasmid DNA or by infection using retroviral vectors. In one case however, the conditionally immortalized TR-BBB cell line was derived from primary cultures of brain endothelial cells of SV40-T-expressing transgenic rats. (3) All cell lines appear to have an endothelial morphology. The absence of foci formation would mean that the cells are not transformed. The endothelial origin is shown by the expression of Factor VIII-related antigen. Immortalized RBE cells express all the enzymes and transporters that are considered as specific for the blood-brain barrier endothelium, with similar characteristics to those expected from in vivo analyses, but at a significantly lower level. Some RBE cell lines are responsive to astroglial factors, such as RBE4 cells, rBEC4, and TR-BBB cells. None of the immortalized RBE cell lines appear to generate the necessary restrictive paracellular barrier properties that would allow to use them in transendothelial permeability screening. (4) RBE cell lines have been used to demonstrate that transporters such as organic cation transporter/carnitine transporter, serotonin transporter, and the ATA2 system A isoform are expressed in rat brain endothelium. When the transporter is shown to be expressed with the same properties in the immortalized RBE cells as in vivo, regulation studies may be initiated even if the transporter is down-regulated. Pharmacological applications have been proposed with well-characterized transporters such as monocarboxylic acid transporter-1, large neutral amino acid tansporter-1, nucleoside carrier systems, and P-glycoprotein. RBE cell monolayers have also been used to investigate the mechanism of the transendothelial transport of large molecules, such as immunoliposomes or nanoparticles, potentially useful as drug delivery vectors to the brain. (5) RBE4 and GP8 cell lines have been extensively used to demonstrate that intercellular adhesion molecule-1 (ICAM-1) engagement in brain endothelial cells triggers multiple signal transduction pathways. Using functional assays, it was established that ICAM-1 signaling is intimately and actively involved in facilitating lymphocyte infiltration. (6) Several RBE cell lines have been described, which constitute tentative in vitro models of the rat BBB. The major limitation of these models generally appears to be due to their relatively high paracellular permeability to small molecules, thus limiting their use for permeability studies. The strategies developed for the production of these RBE cell lines will enable the characterization of still more efficient permeability models, as well as the immortalization of human brain endothelial cells.

Entities:  

Mesh:

Year:  2005        PMID: 15962508     DOI: 10.1007/s10571-004-1376-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  68 in total

1.  In vitro model for evaluating drug transport across the blood-brain barrier.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-04-05       Impact factor: 15.470

2.  Factor(s) released by glucose-deprived astrocytes enhance glucose transporter expression and activity in rat brain endothelial cells.

Authors:  A Régina; S Morchoisne; N D Borson; A L McCall; L R Drewes; F Roux
Journal:  Biochim Biophys Acta       Date:  2001-09-26

Review 3.  Functional expression and localization of P-glycoprotein at the blood brain barrier.

Authors:  Reina Bendayan; Gloria Lee; Moise Bendayan
Journal:  Microsc Res Tech       Date:  2002-06-01       Impact factor: 2.769

4.  A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation.

Authors:  Isabelle Megard; Alexia Garrigues; Stéphane Orlowski; Sylvie Jorajuria; Pascal Clayette; Eric Ezan; Aloïse Mabondzo
Journal:  Brain Res       Date:  2002-02-15       Impact factor: 3.252

5.  Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT.

Authors:  Y T Pham; A Régina; R Farinotti; P Couraud; I W Wainer; F Roux; F Gimenez
Journal:  Biochim Biophys Acta       Date:  2000-12-15

6.  Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway.

Authors:  P Adamson; S Etienne; P O Couraud; V Calder; J Greenwood
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

7.  Lack of histamine synthesis and down-regulation of H1 and H2 receptor mRNA levels by dexamethasone in cerebral endothelial cells.

Authors:  K Karlstedt; T Sallmén; K S Eriksson; M Lintunen; P O Couraud; F Joó; P Panula
Journal:  J Cereb Blood Flow Metab       Date:  1999-03       Impact factor: 6.200

8.  Functional expression of the serotonin transporter in immortalized rat brain microvessel endothelial cells.

Authors:  P Brust; A Friedrich; I A Krizbai; R Bergmann; F Roux; V Ganapathy; B Johannsen
Journal:  J Neurochem       Date:  2000-03       Impact factor: 5.372

9.  ATA2 is predominantly expressed as system A at the blood-brain barrier and acts as brain-to-blood efflux transport for L-proline.

Authors:  Hitomi Takanaga; Noriyo Tokuda; Sumio Ohtsuki; Ken-Ichi Hosoya; Tetsuya Terasaki
Journal:  Mol Pharmacol       Date:  2002-06       Impact factor: 4.436

10.  Evaluation of the RBE4 cell line to explore carrier-mediated drug delivery to the CNS via the L-system amino acid transporter at the blood-brain barrier.

Authors:  Andreas Reichel; N Joan Abbott; David J Begley
Journal:  J Drug Target       Date:  2002-06       Impact factor: 5.121

View more
  57 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  Rat brain endothelial cells are a target of manganese toxicity.

Authors:  Ana Paula Marreilha dos Santos; Dejan Milatovic; Catherine Au; Zhaobao Yin; Maria Camila C Batoreu; Michael Aschner
Journal:  Brain Res       Date:  2010-02-17       Impact factor: 3.252

Review 3.  Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Authors:  Máiria A Deli; Csongor S Abrahám; Yasufumi Kataoka; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

4.  Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.

Authors:  John P Frampton; Michael L Shuler; William Shain; Matthew R Hynd
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2008

Review 5.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

Review 6.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

Review 7.  Myosin light chain kinase signaling in endothelial barrier dysfunction.

Authors:  Robert R Rigor; Qiang Shen; Christopher D Pivetti; Mack H Wu; Sarah Y Yuan
Journal:  Med Res Rev       Date:  2012-08-09       Impact factor: 12.944

8.  Establishment of rat brain endothelial cells susceptible to rat cytomegalovirus ALL-03 infection.

Authors:  Siti-Nazrina Camalxaman; Nazariah Allaudin Zeenathul; Yi-Wan Quah; Hwei-San Loh; Hassan Zuridah; Homayoun Hani; Abdul Rahman Sheikh-Omar; Mohd Lila Mohd-Azmi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-02-22       Impact factor: 2.416

9.  Role of vasodilator stimulated phosphoprotein in VEGF induced blood-brain barrier permeability in endothelial cell monolayers.

Authors:  Brandon Davis; Jun Tang; Li Zhang; Dezhi Mu; Xiangning Jiang; Valerie Biran; Zinaida Vexler; Donna M Ferriero
Journal:  Int J Dev Neurosci       Date:  2010-06-30       Impact factor: 2.457

Review 10.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.